Neuren Pharmaceuticals Ltd
NEU•Health Care•Biotechnology•Last updated: Dec 25
About
Neuren Pharmaceuticals Ltd is a biopharmaceutical company focused on developing therapies for neurodevelopmental disorders. The company primarily operates in the biotechnology sector, with key products including trofinetide and NNZ-2591, which are aimed at treating conditions such as Rett syndrome and Fragile X syndrome. Neuren's operations involve research and development, clinical trials, and partnerships for commercialization.
Share Price Chart
Company Details
- Sector
- Health Care
- Industry
- Biotechnology
- ASX Code
- NEU
Related Shares
Investor Resources
Should you buy Neuren Pharmaceuticals Ltd right now?
While NEU looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.
Join the Rask weekly investment newsletter to get the names, right now